ArticleDrugs - real world outcomes2022

Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases.

Ross A Soo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.